CA
NZ
UK
AU
IND
US
● DataMEDS AI (MEDS) closed at $3.81 on Monday, up 22.51% from $3.11, one of the standout gainers on the Nasdaq.
● Accuray (ARAY) closed near 30 cents on Monday, up roughly 39% from about 22 cents, after touching 38 cents.
● NewGenIvf Group (NIVF) closed at $0.34 on Monday, down 38.44% from $0.56, one of the larger declines amongNasdaqstocks.
● Adicet Bio (ACET) closed at $6.35 on Monday, down 29.60% from $9.02, a steep one-day fall for the clinical-stage biotech.
Shares of Accuray (NASDAQ:ARAY), a penny stock, ended Monday, September 28, 2026 higher by 39.38%, at $0.30. The company is an established maker of radiation-oncology and radiosurgery systems used to treat cancer with targeted radiation.
On Monday, September 28, 2026, Adicet Bio (NASDAQ:ACET) dropped 29.60% to finish at $6.35. The clinical-stage biotech held a webcast on the same day to present Phase 1 data for its lead candidate in lupus.
Shares of Alvotech (NASDAQ:ALVO) ended Monday, September 28, 2026 higher by 6.96%, at $6.15. The biotechnology company develops and manufactures biosimilars, lower-cost follow-on versions of complex biologic medicines that have lost exclusivity.
Coveo Solutions Inc. is a Canadian software company focused on artificial intelligence-powered search, recommendations and digital experience solutions. The company’s platform helps businesses improve customer interactions, enterprise knowledge access and digital commerce experiences through AI-driven relevance technology. The shares gained 2.40% on 28 September …
Shares of Abivax (NASDAQ:ABVX) ended Monday, September 28, 2026 higher by 6.36%, at $96.85. The clinical-stage biotech, listed in the United States and rooted in France, has drawn intense investor attention for its lead candidate in ulcerative colitis.
● Firefly Neuroscience (AIFF) closed at $1.69 on Monday, down 15.92% from $2.01, giving back part of Friday's surge.
Please wait processing your request...